Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Griffioen

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Oncogene|March 7, 2012
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1J R van Beijnum, P Nowak-Sliwinska, E van den Boezem, et al.
Cell Adhesion and Communication|July 1, 1994
Expression of CD44 splice variants during lymphocyte activation and tumor progressionA W Griffioen, E Horst, K H Heider, et al.
International Journal of Cancer|February 6, 1999
Angiogenesis inhibitors overcome tumor induced endothelial cell anergyA W Griffioen, C A Damen, K H Mayo, et al.
Oncogene|September 22, 2010
Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanomaE Pardali, D W J van der Schaft, E Wiercinska, et al.
International Journal of Immunopathology and Pharmacology|December 15, 2006
Endothelial cell anergy is mediated by bFGF through the sustained activation of p38-MAPK and NF-kappaB inhibitionV Flati, L I Pastore, A W Griffioen, et al.
British Journal of Cancer|March 10, 2011
Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factorsI V Bijnsdorp, F Capriotti, F A E Kruyt, et al.
Blood|August 1, 1997
CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cellsA W Griffioen, M J Coenen, C A Damen, et al.
Angiogenesis|October 1, 2003
The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditionsA W Griffioen, I A Relou, H I Gallardo Torres, et al.
The Biochemical Journal|February 15, 2001
Anginex, a designed peptide that inhibits angiogenesisA W Griffioen, D W van der Schaft, A F Barendsz-Janson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1992
Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cellsW B De Lau, S E Boom, K Heije, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Oncogene|March 7, 2012
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1J R van Beijnum, P Nowak-Sliwinska, E van den Boezem, et al.
Cell Adhesion and Communication|July 1, 1994
Expression of CD44 splice variants during lymphocyte activation and tumor progressionA W Griffioen, E Horst, K H Heider, et al.
International Journal of Cancer|February 6, 1999
Angiogenesis inhibitors overcome tumor induced endothelial cell anergyA W Griffioen, C A Damen, K H Mayo, et al.
Oncogene|September 22, 2010
Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanomaE Pardali, D W J van der Schaft, E Wiercinska, et al.
International Journal of Immunopathology and Pharmacology|December 15, 2006
Endothelial cell anergy is mediated by bFGF through the sustained activation of p38-MAPK and NF-kappaB inhibitionV Flati, L I Pastore, A W Griffioen, et al.
British Journal of Cancer|March 10, 2011
Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factorsI V Bijnsdorp, F Capriotti, F A E Kruyt, et al.
Blood|August 1, 1997
CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cellsA W Griffioen, M J Coenen, C A Damen, et al.
Angiogenesis|October 1, 2003
The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditionsA W Griffioen, I A Relou, H I Gallardo Torres, et al.
The Biochemical Journal|February 15, 2001
Anginex, a designed peptide that inhibits angiogenesisA W Griffioen, D W van der Schaft, A F Barendsz-Janson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1992
Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cellsW B De Lau, S E Boom, K Heije, et al.
Pageof 5